EdgarLookup

American Heritage International Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that American Heritage International Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-219.4%
Return on Assets
Net income ÷ assets
-2.66x
Debt-to-Equity
Total liabilities ÷ equity

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $13 Mar 31, 2014
FY2012 Dec 31, 2012 $16.4K Mar 4, 2013

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 ($168.8K) Mar 31, 2014
FY2013 Dec 31, 2012 ($99.7K) Mar 31, 2014
FY2013 Dec 31, 2011 ($31.1K) Mar 31, 2014
FY2013 Dec 31, 2010 ($12.2K) Mar 31, 2014

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 ($97.6K) Mar 4, 2013
FY2012 Dec 31, 2011 ($31.1K) Mar 4, 2013

R&D Expense

Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $12.2K Mar 4, 2013
FY2012 Dec 31, 2011 $2.3K Mar 4, 2013

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 ($120.5K) Mar 31, 2014
FY2013 Dec 31, 2012 ($84.4K) Mar 31, 2014
FY2012 Dec 31, 2011 ($20.4K) Mar 4, 2013

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $76.9K Mar 31, 2014
FY2013 Dec 31, 2012 $5.5K Mar 31, 2014
FY2012 Dec 31, 2011 $7.4K Mar 4, 2013

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $123.3K Mar 31, 2014
FY2013 Dec 31, 2012 $79.5K Mar 31, 2014
FY2012 Dec 31, 2011 $16.2K Mar 4, 2013

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 ($46.3K) Mar 31, 2014
FY2013 Dec 31, 2012 ($73.9K) Mar 31, 2014
FY2013 Dec 31, 2011 ($8.8K) Mar 31, 2014
FY2013 Dec 31, 2010 $1.3K Mar 31, 2014

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $0 Mar 31, 2014
FY2013 Dec 31, 2012 $0 Mar 31, 2014
FY2012 Dec 31, 2011 $1.9K Mar 4, 2013
FY2012 Dec 31, 2010 $1.3K Mar 4, 2013

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2012 $50.0K Mar 31, 2014

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 99.00M Mar 31, 2014
FY2013 Dec 31, 2012 145.50M Mar 31, 2014
FY2012 Dec 31, 2011 72.75M Mar 4, 2013